2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation
Transcatheter aortic valve implantation (TAVI) has spawned the evolution of novel catheter-
based therapies for a variety of cardiovascular conditions. Newer device iterations are …
based therapies for a variety of cardiovascular conditions. Newer device iterations are …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement
P Généreux, DJ Cohen, M Mack… - Journal of the American …, 2014 - jacc.org
Background: The incidence and prognostic impact of late bleeding complications after
transcatheter aortic valve replacement (TAVR) are unknown. Objectives: The aim of this …
transcatheter aortic valve replacement (TAVR) are unknown. Objectives: The aim of this …
Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement
Background: Identifying transcatheter aortic valve replacement (TAVR) patients at high risk
for cerebrovascular events (CVE) is of major clinical relevance. However, predictors have …
for cerebrovascular events (CVE) is of major clinical relevance. However, predictors have …
2018 AATS/ACC/SCAI/STS expert consensus systems of care document: operator and institutional recommendations and requirements for transcatheter aortic valve …
JE Bavaria, CL Tommaso, RG Brindis, JD Carroll… - Journal of the American …, 2019 - jacc.org
Registry data that shows a clinically meaningful association of higher mortality and other
major complications with site annual volume below the recommended threshold of 50 …
major complications with site annual volume below the recommended threshold of 50 …
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome
Atrial fibrillation (AF) is a common arrhythmia in patients with aortic stenosis. When these
patients are treated medically or by surgical aortic valve replacement, AF is associated with …
patients are treated medically or by surgical aortic valve replacement, AF is associated with …
[HTML][HTML] Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral
annular and aortic valve calcifications are highly prevalent in CKD patients and commonly …
annular and aortic valve calcifications are highly prevalent in CKD patients and commonly …